Precision Medical Ventures Inc. (PMV) is an innovative investment group dedicated to advancing medical technology, particularly within the realms of radiology and healthcare. The company is committed to enhancing patient care and outcomes by developing cutting-edge medical devices and software solutions that address critical challenges in healthcare delivery.
Company Values
PMV stands out for introducing RevealAI-Lung, the world's first regulatory-cleared CADx software for lung nodule characterization, which significantly enhances diagnostic accuracy and reduces healthcare costs.